The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill Patients Have Access to Life-Saving Ultrafiltration Therapy
April 08, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) -- Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New...
CHF Solutions Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems
March 11, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 11, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Puerto Rico
March 09, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 09, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
March 04, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will...
CHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update
March 02, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 02, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter ended December 31, 2020. Recent Highlights Revenue for...
CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
February 03, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
January 28, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
January 12, 2021 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF
December 15, 2020 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions, Inc. Announces 52 Percent Increase in Revenue for Third Quarter 2020 and Provides Company Update
November 10, 2020 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the third quarter ended September 30, 2020. Recent Highlights Revenue for...